Get 20% lifetime commission for referring investors to digrin.com
here.
Immunic, Inc. ( IMUX) - Stock Earnings
IMUX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
IMUX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -19.3 million USD | — USD |
| 2026Q1 | -32.6 million USD | — USD |
| 2026Q2 | -34.1 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IMUX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -93.6 million USD | — USD |
| 2024 | -100.5 million USD | — USD |
| 2025 | -97.2 million USD | — USD |
| 2026 Est. | — | — |
IMUX
Price: $6.97
52 week price:
Earnings Per Share: -3.67 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 562646
Market Capitalization: 108.4 million